nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—Fenofibrate—coronary artery disease	0.31	1	CrCtD
Bezafibrate—HMGCR—coronary artery disease	0.0969	0.68	CbGaD
Bezafibrate—Etofibrate—Fenofibrate—coronary artery disease	0.0745	0.391	CrCrCtD
Bezafibrate—Clofibrate—Fenofibrate—coronary artery disease	0.0623	0.327	CrCrCtD
Bezafibrate—Indomethacin—Fenofibrate—coronary artery disease	0.0538	0.282	CrCrCtD
Bezafibrate—PPARA—Fenofibrate—coronary artery disease	0.0495	0.193	CbGbCtD
Bezafibrate—PPARG—coronary artery disease	0.0457	0.32	CbGaD
Bezafibrate—PPARA—Gemfibrozil—coronary artery disease	0.0396	0.154	CbGbCtD
Bezafibrate—HMGCR—Pitavastatin—coronary artery disease	0.0206	0.0802	CbGbCtD
Bezafibrate—HMGCR—Rosuvastatin—coronary artery disease	0.0152	0.0591	CbGbCtD
Bezafibrate—HMGCR—Simvastatin—coronary artery disease	0.0141	0.055	CbGbCtD
Bezafibrate—HMGCR—Pravastatin—coronary artery disease	0.0138	0.0538	CbGbCtD
Bezafibrate—HMGCR—Lovastatin—coronary artery disease	0.0138	0.0538	CbGbCtD
Bezafibrate—HMGCR—Atorvastatin—coronary artery disease	0.0126	0.049	CbGbCtD
Bezafibrate—PPARG—Telmisartan—coronary artery disease	0.0125	0.0485	CbGbCtD
Bezafibrate—SLCO1B1—Gemfibrozil—coronary artery disease	0.00565	0.022	CbGbCtD
Bezafibrate—SLCO1B1—Olmesartan—coronary artery disease	0.00535	0.0209	CbGbCtD
Bezafibrate—SLCO1B1—Pitavastatin—coronary artery disease	0.00428	0.0167	CbGbCtD
Bezafibrate—SLCO1B1—Valsartan—coronary artery disease	0.00416	0.0162	CbGbCtD
Bezafibrate—SLCO1B1—Rosuvastatin—coronary artery disease	0.00315	0.0123	CbGbCtD
Bezafibrate—SLCO1B1—Ezetimibe—coronary artery disease	0.00315	0.0123	CbGbCtD
Bezafibrate—CYP2C8—Fenofibrate—coronary artery disease	0.00299	0.0116	CbGbCtD
Bezafibrate—SLCO1B1—Simvastatin—coronary artery disease	0.00293	0.0114	CbGbCtD
Bezafibrate—SLCO1B1—Lovastatin—coronary artery disease	0.00287	0.0112	CbGbCtD
Bezafibrate—SLCO1B1—Pravastatin—coronary artery disease	0.00287	0.0112	CbGbCtD
Bezafibrate—SLCO1B1—Atorvastatin—coronary artery disease	0.00261	0.0102	CbGbCtD
Bezafibrate—SLCO1B1—Losartan—coronary artery disease	0.00239	0.00932	CbGbCtD
Bezafibrate—CYP2C8—Gemfibrozil—coronary artery disease	0.00239	0.00931	CbGbCtD
Bezafibrate—CYP2C8—Clopidogrel—coronary artery disease	0.00207	0.00807	CbGbCtD
Bezafibrate—CYP2C8—Pitavastatin—coronary artery disease	0.00181	0.00706	CbGbCtD
Bezafibrate—CYP3A4—Ticagrelor—coronary artery disease	0.00136	0.0053	CbGbCtD
Bezafibrate—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0013	0.00507	CbGbCtD
Bezafibrate—CYP2C8—Simvastatin—coronary artery disease	0.00124	0.00484	CbGbCtD
Bezafibrate—CYP2C8—Lovastatin—coronary artery disease	0.00121	0.00473	CbGbCtD
Bezafibrate—CYP2C8—Pravastatin—coronary artery disease	0.00121	0.00473	CbGbCtD
Bezafibrate—CYP3A4—Fenofibrate—coronary artery disease	0.00121	0.00472	CbGbCtD
Bezafibrate—CYP2C8—Atorvastatin—coronary artery disease	0.00111	0.00431	CbGbCtD
Bezafibrate—CYP2C8—Losartan—coronary artery disease	0.00101	0.00394	CbGbCtD
Bezafibrate—CYP3A4—Gemfibrozil—coronary artery disease	0.000969	0.00378	CbGbCtD
Bezafibrate—CYP3A4—Clopidogrel—coronary artery disease	0.00084	0.00327	CbGbCtD
Bezafibrate—CYP3A4—Eplerenone—coronary artery disease	0.000781	0.00304	CbGbCtD
Bezafibrate—CYP3A4—Enalapril—coronary artery disease	0.000696	0.00271	CbGbCtD
Bezafibrate—CYP3A4—Ezetimibe—coronary artery disease	0.000541	0.00211	CbGbCtD
Bezafibrate—CYP3A4—Rosuvastatin—coronary artery disease	0.000541	0.00211	CbGbCtD
Bezafibrate—CYP3A4—Simvastatin—coronary artery disease	0.000503	0.00196	CbGbCtD
Bezafibrate—CYP3A4—Lovastatin—coronary artery disease	0.000493	0.00192	CbGbCtD
Bezafibrate—CYP3A4—Pravastatin—coronary artery disease	0.000493	0.00192	CbGbCtD
Bezafibrate—CYP3A4—Atorvastatin—coronary artery disease	0.000449	0.00175	CbGbCtD
Bezafibrate—CYP3A4—Losartan—coronary artery disease	0.00041	0.0016	CbGbCtD
Bezafibrate—PPARG—artery—coronary artery disease	0.00037	0.0937	CbGeAlD
Bezafibrate—PPARA—myocardium—coronary artery disease	0.000355	0.0899	CbGeAlD
Bezafibrate—PPARG—endothelium—coronary artery disease	0.000313	0.0791	CbGeAlD
Bezafibrate—PPARD—heart—coronary artery disease	0.000291	0.0736	CbGeAlD
Bezafibrate—Indomethacin—PLA2G2A—coronary artery disease	0.000253	0.227	CrCbGaD
Bezafibrate—PPARA—heart—coronary artery disease	0.000248	0.0627	CbGeAlD
Bezafibrate—HMGCR—myocardium—coronary artery disease	0.000237	0.0598	CbGeAlD
Bezafibrate—PPARA—cardiovascular system—coronary artery disease	0.000234	0.0592	CbGeAlD
Bezafibrate—PPARG—myocardium—coronary artery disease	0.000195	0.0494	CbGeAlD
Bezafibrate—PPARA—blood—coronary artery disease	0.000185	0.0468	CbGeAlD
Bezafibrate—HMGCR—heart—coronary artery disease	0.000165	0.0417	CbGeAlD
Bezafibrate—HMGCR—cardiovascular system—coronary artery disease	0.000156	0.0394	CbGeAlD
Bezafibrate—Glyburide—CFTR—coronary artery disease	0.000154	0.139	CrCbGaD
Bezafibrate—HMGCR—cardiac atrium—coronary artery disease	0.000141	0.0357	CbGeAlD
Bezafibrate—PPARG—heart—coronary artery disease	0.000136	0.0345	CbGeAlD
Bezafibrate—Glyburide—ABCA1—coronary artery disease	0.000131	0.118	CrCbGaD
Bezafibrate—PPARG—cardiovascular system—coronary artery disease	0.000129	0.0326	CbGeAlD
Bezafibrate—CYP1A1—cardiac ventricle—coronary artery disease	0.000126	0.032	CbGeAlD
Bezafibrate—HMGCR—blood—coronary artery disease	0.000123	0.0312	CbGeAlD
Bezafibrate—SLCO1B1—blood—coronary artery disease	0.000118	0.0298	CbGeAlD
Bezafibrate—Balsalazide—PPARG—coronary artery disease	0.000118	0.106	CrCbGaD
Bezafibrate—PPARG—blood—coronary artery disease	0.000102	0.0257	CbGeAlD
Bezafibrate—CYP1A1—heart—coronary artery disease	8.3e-05	0.021	CbGeAlD
Bezafibrate—Ritodrine—ADRB2—coronary artery disease	8.15e-05	0.0733	CrCbGaD
Bezafibrate—Indomethacin—CXCL8—coronary artery disease	7.5e-05	0.0674	CrCbGaD
Bezafibrate—Moclobemide—CYP2C19—coronary artery disease	7.29e-05	0.0655	CrCbGaD
Bezafibrate—CYP1A1—cardiac atrium—coronary artery disease	7.1e-05	0.018	CbGeAlD
Bezafibrate—CYP2C8—blood—coronary artery disease	6.71e-05	0.017	CbGeAlD
Bezafibrate—CYP1A1—blood—coronary artery disease	6.19e-05	0.0157	CbGeAlD
Bezafibrate—Indomethacin—PPARG—coronary artery disease	5.18e-05	0.0466	CrCbGaD
Bezafibrate—Balsalazide—PTGS2—coronary artery disease	4.96e-05	0.0446	CrCbGaD
Bezafibrate—CYP3A4—blood—coronary artery disease	4.55e-05	0.0115	CbGeAlD
Bezafibrate—Indomethacin—CYP2C19—coronary artery disease	3.51e-05	0.0316	CrCbGaD
Bezafibrate—Constipation—Pravastatin—coronary artery disease	3.26e-05	0.000603	CcSEcCtD
Bezafibrate—Pain—Pravastatin—coronary artery disease	3.26e-05	0.000603	CcSEcCtD
Bezafibrate—Dyspepsia—Trandolapril—coronary artery disease	3.26e-05	0.000603	CcSEcCtD
Bezafibrate—Rash—Acetylsalicylic acid—coronary artery disease	3.25e-05	0.000603	CcSEcCtD
Bezafibrate—Hypersensitivity—Ezetimibe—coronary artery disease	3.25e-05	0.000603	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Valsartan—coronary artery disease	3.25e-05	0.000602	CcSEcCtD
Bezafibrate—Dermatitis—Acetylsalicylic acid—coronary artery disease	3.25e-05	0.000602	CcSEcCtD
Bezafibrate—Muscle spasms—Ramipril—coronary artery disease	3.25e-05	0.000602	CcSEcCtD
Bezafibrate—Dyspepsia—Enalapril—coronary artery disease	3.24e-05	0.0006	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Olmesartan—coronary artery disease	3.24e-05	0.0006	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Captopril—coronary artery disease	3.22e-05	0.000596	CcSEcCtD
Bezafibrate—Pruritus—Clopidogrel—coronary artery disease	3.21e-05	0.000594	CcSEcCtD
Bezafibrate—Dyspepsia—Telmisartan—coronary artery disease	3.2e-05	0.000592	CcSEcCtD
Bezafibrate—Infection—Losartan—coronary artery disease	3.2e-05	0.000592	CcSEcCtD
Bezafibrate—Insomnia—Captopril—coronary artery disease	3.19e-05	0.000592	CcSEcCtD
Bezafibrate—Pruritus—Lovastatin—coronary artery disease	3.19e-05	0.00059	CcSEcCtD
Bezafibrate—Glyburide—CYP2C19—coronary artery disease	3.17e-05	0.0285	CrCbGaD
Bezafibrate—Gastrointestinal pain—Niacin—coronary artery disease	3.16e-05	0.000586	CcSEcCtD
Bezafibrate—Constipation—Trandolapril—coronary artery disease	3.16e-05	0.000586	CcSEcCtD
Bezafibrate—Urticaria—Valsartan—coronary artery disease	3.16e-05	0.000585	CcSEcCtD
Bezafibrate—Nausea—Rosuvastatin—coronary artery disease	3.16e-05	0.000585	CcSEcCtD
Bezafibrate—Diarrhoea—Fenofibrate—coronary artery disease	3.16e-05	0.000584	CcSEcCtD
Bezafibrate—Thrombocytopenia—Losartan—coronary artery disease	3.15e-05	0.000583	CcSEcCtD
Bezafibrate—Constipation—Enalapril—coronary artery disease	3.15e-05	0.000583	CcSEcCtD
Bezafibrate—Urticaria—Olmesartan—coronary artery disease	3.14e-05	0.000582	CcSEcCtD
Bezafibrate—Abdominal pain—Valsartan—coronary artery disease	3.14e-05	0.000582	CcSEcCtD
Bezafibrate—Abdominal pain—Olmesartan—coronary artery disease	3.13e-05	0.00058	CcSEcCtD
Bezafibrate—Pruritus—Ezetimibe—coronary artery disease	3.12e-05	0.000579	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Perindopril—coronary artery disease	3.12e-05	0.000579	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Pravastatin—coronary artery disease	3.11e-05	0.000577	CcSEcCtD
Bezafibrate—Alopecia—Lisinopril—coronary artery disease	3.11e-05	0.000576	CcSEcCtD
Bezafibrate—Dyspepsia—Captopril—coronary artery disease	3.11e-05	0.000576	CcSEcCtD
Bezafibrate—Pain—Telmisartan—coronary artery disease	3.11e-05	0.000575	CcSEcCtD
Bezafibrate—Constipation—Telmisartan—coronary artery disease	3.11e-05	0.000575	CcSEcCtD
Bezafibrate—Hypersensitivity—Simvastatin—coronary artery disease	3.1e-05	0.000575	CcSEcCtD
Bezafibrate—Insomnia—Perindopril—coronary artery disease	3.1e-05	0.000575	CcSEcCtD
Bezafibrate—Diarrhoea—Clopidogrel—coronary artery disease	3.1e-05	0.000574	CcSEcCtD
Bezafibrate—Diarrhoea—Lovastatin—coronary artery disease	3.08e-05	0.000571	CcSEcCtD
Bezafibrate—Urticaria—Niacin—coronary artery disease	3.07e-05	0.000569	CcSEcCtD
Bezafibrate—Nausea—Acetylsalicylic acid—coronary artery disease	3.07e-05	0.000568	CcSEcCtD
Bezafibrate—Erythema—Lisinopril—coronary artery disease	3.07e-05	0.000568	CcSEcCtD
Bezafibrate—Pruritus—Eplerenone—coronary artery disease	3.06e-05	0.000566	CcSEcCtD
Bezafibrate—Abdominal pain—Niacin—coronary artery disease	3.06e-05	0.000566	CcSEcCtD
Bezafibrate—Dizziness—Fenofibrate—coronary artery disease	3.05e-05	0.000565	CcSEcCtD
Bezafibrate—Urticaria—Pravastatin—coronary artery disease	3.03e-05	0.00056	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Trandolapril—coronary artery disease	3.02e-05	0.00056	CcSEcCtD
Bezafibrate—Diarrhoea—Ezetimibe—coronary artery disease	3.02e-05	0.00056	CcSEcCtD
Bezafibrate—Constipation—Captopril—coronary artery disease	3.02e-05	0.00056	CcSEcCtD
Bezafibrate—Flatulence—Lisinopril—coronary artery disease	3.02e-05	0.000559	CcSEcCtD
Bezafibrate—Dyspepsia—Perindopril—coronary artery disease	3.02e-05	0.000559	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Enalapril—coronary artery disease	3.01e-05	0.000558	CcSEcCtD
Bezafibrate—Abdominal pain—Pravastatin—coronary artery disease	3.01e-05	0.000558	CcSEcCtD
Bezafibrate—Dizziness—Clopidogrel—coronary artery disease	3e-05	0.000555	CcSEcCtD
Bezafibrate—Pruritus—Simvastatin—coronary artery disease	2.98e-05	0.000552	CcSEcCtD
Bezafibrate—Dizziness—Lovastatin—coronary artery disease	2.98e-05	0.000552	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Telmisartan—coronary artery disease	2.97e-05	0.00055	CcSEcCtD
Bezafibrate—Diarrhoea—Eplerenone—coronary artery disease	2.96e-05	0.000548	CcSEcCtD
Bezafibrate—Muscle spasms—Lisinopril—coronary artery disease	2.95e-05	0.000546	CcSEcCtD
Bezafibrate—Urticaria—Trandolapril—coronary artery disease	2.94e-05	0.000544	CcSEcCtD
Bezafibrate—Pain—Perindopril—coronary artery disease	2.93e-05	0.000543	CcSEcCtD
Bezafibrate—Constipation—Perindopril—coronary artery disease	2.93e-05	0.000543	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Losartan—coronary artery disease	2.93e-05	0.000543	CcSEcCtD
Bezafibrate—Hypersensitivity—Valsartan—coronary artery disease	2.93e-05	0.000543	CcSEcCtD
Bezafibrate—Urticaria—Enalapril—coronary artery disease	2.93e-05	0.000542	CcSEcCtD
Bezafibrate—Abdominal pain—Trandolapril—coronary artery disease	2.92e-05	0.000541	CcSEcCtD
Bezafibrate—Dizziness—Ezetimibe—coronary artery disease	2.92e-05	0.000541	CcSEcCtD
Bezafibrate—Abdominal pain—Enalapril—coronary artery disease	2.91e-05	0.000539	CcSEcCtD
Bezafibrate—Insomnia—Losartan—coronary artery disease	2.91e-05	0.000539	CcSEcCtD
Bezafibrate—Rash—Fenofibrate—coronary artery disease	2.91e-05	0.000539	CcSEcCtD
Bezafibrate—Dermatitis—Fenofibrate—coronary artery disease	2.9e-05	0.000538	CcSEcCtD
Bezafibrate—Headache—Fenofibrate—coronary artery disease	2.89e-05	0.000535	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Captopril—coronary artery disease	2.89e-05	0.000535	CcSEcCtD
Bezafibrate—Urticaria—Telmisartan—coronary artery disease	2.89e-05	0.000535	CcSEcCtD
Bezafibrate—Diarrhoea—Simvastatin—coronary artery disease	2.88e-05	0.000534	CcSEcCtD
Bezafibrate—Myalgia—Ramipril—coronary artery disease	2.88e-05	0.000533	CcSEcCtD
Bezafibrate—Abdominal pain—Telmisartan—coronary artery disease	2.87e-05	0.000532	CcSEcCtD
Bezafibrate—Dizziness—Eplerenone—coronary artery disease	2.86e-05	0.000529	CcSEcCtD
Bezafibrate—Rash—Clopidogrel—coronary artery disease	2.86e-05	0.000529	CcSEcCtD
Bezafibrate—Dermatitis—Clopidogrel—coronary artery disease	2.86e-05	0.000529	CcSEcCtD
Bezafibrate—Pain—Furosemide—coronary artery disease	2.85e-05	0.000528	CcSEcCtD
Bezafibrate—Constipation—Furosemide—coronary artery disease	2.85e-05	0.000528	CcSEcCtD
Bezafibrate—Hypersensitivity—Niacin—coronary artery disease	2.85e-05	0.000528	CcSEcCtD
Bezafibrate—Headache—Clopidogrel—coronary artery disease	2.84e-05	0.000526	CcSEcCtD
Bezafibrate—Rash—Lovastatin—coronary artery disease	2.84e-05	0.000526	CcSEcCtD
Bezafibrate—Dermatitis—Lovastatin—coronary artery disease	2.84e-05	0.000525	CcSEcCtD
Bezafibrate—Anaemia—Lisinopril—coronary artery disease	2.83e-05	0.000525	CcSEcCtD
Bezafibrate—Dyspepsia—Losartan—coronary artery disease	2.83e-05	0.000524	CcSEcCtD
Bezafibrate—Headache—Lovastatin—coronary artery disease	2.82e-05	0.000523	CcSEcCtD
Bezafibrate—Pruritus—Valsartan—coronary artery disease	2.81e-05	0.000521	CcSEcCtD
Bezafibrate—Myalgia—Timolol—coronary artery disease	2.81e-05	0.000521	CcSEcCtD
Bezafibrate—Hypersensitivity—Pravastatin—coronary artery disease	2.81e-05	0.00052	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Perindopril—coronary artery disease	2.8e-05	0.000519	CcSEcCtD
Bezafibrate—Pruritus—Olmesartan—coronary artery disease	2.8e-05	0.000519	CcSEcCtD
Bezafibrate—Abdominal pain—Captopril—coronary artery disease	2.79e-05	0.000517	CcSEcCtD
Bezafibrate—Dizziness—Simvastatin—coronary artery disease	2.79e-05	0.000516	CcSEcCtD
Bezafibrate—Rash—Ezetimibe—coronary artery disease	2.78e-05	0.000516	CcSEcCtD
Bezafibrate—Dermatitis—Ezetimibe—coronary artery disease	2.78e-05	0.000515	CcSEcCtD
Bezafibrate—Headache—Ezetimibe—coronary artery disease	2.77e-05	0.000512	CcSEcCtD
Bezafibrate—Pain—Losartan—coronary artery disease	2.75e-05	0.00051	CcSEcCtD
Bezafibrate—Constipation—Losartan—coronary artery disease	2.75e-05	0.00051	CcSEcCtD
Bezafibrate—Nausea—Fenofibrate—coronary artery disease	2.74e-05	0.000507	CcSEcCtD
Bezafibrate—Pruritus—Niacin—coronary artery disease	2.74e-05	0.000507	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Furosemide—coronary artery disease	2.73e-05	0.000505	CcSEcCtD
Bezafibrate—Rash—Eplerenone—coronary artery disease	2.73e-05	0.000505	CcSEcCtD
Bezafibrate—Urticaria—Perindopril—coronary artery disease	2.72e-05	0.000505	CcSEcCtD
Bezafibrate—Hypersensitivity—Trandolapril—coronary artery disease	2.72e-05	0.000505	CcSEcCtD
Bezafibrate—Dermatitis—Eplerenone—coronary artery disease	2.72e-05	0.000504	CcSEcCtD
Bezafibrate—Diarrhoea—Valsartan—coronary artery disease	2.72e-05	0.000504	CcSEcCtD
Bezafibrate—Hypersensitivity—Enalapril—coronary artery disease	2.71e-05	0.000503	CcSEcCtD
Bezafibrate—Abdominal pain—Perindopril—coronary artery disease	2.71e-05	0.000502	CcSEcCtD
Bezafibrate—Diarrhoea—Olmesartan—coronary artery disease	2.71e-05	0.000502	CcSEcCtD
Bezafibrate—Headache—Eplerenone—coronary artery disease	2.71e-05	0.000502	CcSEcCtD
Bezafibrate—Thrombocytopenia—Ramipril—coronary artery disease	2.7e-05	0.0005	CcSEcCtD
Bezafibrate—Pruritus—Pravastatin—coronary artery disease	2.69e-05	0.000499	CcSEcCtD
Bezafibrate—Nausea—Clopidogrel—coronary artery disease	2.69e-05	0.000499	CcSEcCtD
Bezafibrate—Infection—Timolol—coronary artery disease	2.68e-05	0.000496	CcSEcCtD
Bezafibrate—Hypersensitivity—Telmisartan—coronary artery disease	2.68e-05	0.000496	CcSEcCtD
Bezafibrate—Nausea—Lovastatin—coronary artery disease	2.67e-05	0.000495	CcSEcCtD
Bezafibrate—Rash—Simvastatin—coronary artery disease	2.66e-05	0.000492	CcSEcCtD
Bezafibrate—Dermatitis—Simvastatin—coronary artery disease	2.65e-05	0.000491	CcSEcCtD
Bezafibrate—Urticaria—Furosemide—coronary artery disease	2.65e-05	0.000491	CcSEcCtD
Bezafibrate—Diarrhoea—Niacin—coronary artery disease	2.65e-05	0.00049	CcSEcCtD
Bezafibrate—Headache—Simvastatin—coronary artery disease	2.64e-05	0.000489	CcSEcCtD
Bezafibrate—Abdominal pain—Furosemide—coronary artery disease	2.64e-05	0.000488	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Losartan—coronary artery disease	2.63e-05	0.000487	CcSEcCtD
Bezafibrate—Dizziness—Valsartan—coronary artery disease	2.63e-05	0.000487	CcSEcCtD
Bezafibrate—Nausea—Ezetimibe—coronary artery disease	2.62e-05	0.000486	CcSEcCtD
Bezafibrate—Dizziness—Olmesartan—coronary artery disease	2.62e-05	0.000485	CcSEcCtD
Bezafibrate—Pruritus—Trandolapril—coronary artery disease	2.62e-05	0.000485	CcSEcCtD
Bezafibrate—Myalgia—Lisinopril—coronary artery disease	2.61e-05	0.000483	CcSEcCtD
Bezafibrate—Pruritus—Enalapril—coronary artery disease	2.61e-05	0.000483	CcSEcCtD
Bezafibrate—Diarrhoea—Pravastatin—coronary artery disease	2.61e-05	0.000483	CcSEcCtD
Bezafibrate—Pruritus—Telmisartan—coronary artery disease	2.57e-05	0.000476	CcSEcCtD
Bezafibrate—Nausea—Eplerenone—coronary artery disease	2.57e-05	0.000476	CcSEcCtD
Bezafibrate—Dizziness—Niacin—coronary artery disease	2.56e-05	0.000474	CcSEcCtD
Bezafibrate—Urticaria—Losartan—coronary artery disease	2.56e-05	0.000473	CcSEcCtD
Bezafibrate—Abdominal pain—Losartan—coronary artery disease	2.54e-05	0.000471	CcSEcCtD
Bezafibrate—Diarrhoea—Trandolapril—coronary artery disease	2.53e-05	0.000469	CcSEcCtD
Bezafibrate—Diarrhoea—Enalapril—coronary artery disease	2.52e-05	0.000467	CcSEcCtD
Bezafibrate—Dizziness—Pravastatin—coronary artery disease	2.52e-05	0.000466	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.51e-05	0.000465	CcSEcCtD
Bezafibrate—Rash—Valsartan—coronary artery disease	2.51e-05	0.000465	CcSEcCtD
Bezafibrate—Dermatitis—Valsartan—coronary artery disease	2.51e-05	0.000464	CcSEcCtD
Bezafibrate—Nausea—Simvastatin—coronary artery disease	2.5e-05	0.000463	CcSEcCtD
Bezafibrate—Pruritus—Captopril—coronary artery disease	2.5e-05	0.000463	CcSEcCtD
Bezafibrate—Rash—Olmesartan—coronary artery disease	2.5e-05	0.000462	CcSEcCtD
Bezafibrate—Insomnia—Ramipril—coronary artery disease	2.49e-05	0.000462	CcSEcCtD
Bezafibrate—Dermatitis—Olmesartan—coronary artery disease	2.49e-05	0.000462	CcSEcCtD
Bezafibrate—Headache—Valsartan—coronary artery disease	2.49e-05	0.000462	CcSEcCtD
Bezafibrate—Diarrhoea—Telmisartan—coronary artery disease	2.49e-05	0.00046	CcSEcCtD
Bezafibrate—Infection—Lisinopril—coronary artery disease	2.49e-05	0.00046	CcSEcCtD
Bezafibrate—Headache—Olmesartan—coronary artery disease	2.48e-05	0.000459	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Timolol—coronary artery disease	2.46e-05	0.000455	CcSEcCtD
Bezafibrate—Hypersensitivity—Furosemide—coronary artery disease	2.46e-05	0.000455	CcSEcCtD
Bezafibrate—Thrombocytopenia—Lisinopril—coronary artery disease	2.45e-05	0.000454	CcSEcCtD
Bezafibrate—Dizziness—Trandolapril—coronary artery disease	2.45e-05	0.000453	CcSEcCtD
Bezafibrate—Insomnia—Timolol—coronary artery disease	2.44e-05	0.000452	CcSEcCtD
Bezafibrate—Rash—Niacin—coronary artery disease	2.44e-05	0.000452	CcSEcCtD
Bezafibrate—Dermatitis—Niacin—coronary artery disease	2.44e-05	0.000451	CcSEcCtD
Bezafibrate—Dizziness—Enalapril—coronary artery disease	2.44e-05	0.000451	CcSEcCtD
Bezafibrate—Dyspepsia—Ramipril—coronary artery disease	2.43e-05	0.00045	CcSEcCtD
Bezafibrate—Pruritus—Perindopril—coronary artery disease	2.43e-05	0.000449	CcSEcCtD
Bezafibrate—Headache—Niacin—coronary artery disease	2.42e-05	0.000449	CcSEcCtD
Bezafibrate—Diarrhoea—Captopril—coronary artery disease	2.42e-05	0.000448	CcSEcCtD
Bezafibrate—Dizziness—Telmisartan—coronary artery disease	2.4e-05	0.000445	CcSEcCtD
Bezafibrate—Rash—Pravastatin—coronary artery disease	2.4e-05	0.000445	CcSEcCtD
Bezafibrate—Dermatitis—Pravastatin—coronary artery disease	2.4e-05	0.000444	CcSEcCtD
Bezafibrate—Headache—Pravastatin—coronary artery disease	2.39e-05	0.000442	CcSEcCtD
Bezafibrate—Dyspepsia—Timolol—coronary artery disease	2.37e-05	0.00044	CcSEcCtD
Bezafibrate—Hypersensitivity—Losartan—coronary artery disease	2.37e-05	0.000439	CcSEcCtD
Bezafibrate—Nausea—Valsartan—coronary artery disease	2.36e-05	0.000438	CcSEcCtD
Bezafibrate—Pruritus—Furosemide—coronary artery disease	2.36e-05	0.000437	CcSEcCtD
Bezafibrate—Constipation—Ramipril—coronary artery disease	2.36e-05	0.000437	CcSEcCtD
Bezafibrate—Nausea—Olmesartan—coronary artery disease	2.35e-05	0.000436	CcSEcCtD
Bezafibrate—Diarrhoea—Perindopril—coronary artery disease	2.35e-05	0.000435	CcSEcCtD
Bezafibrate—Dizziness—Captopril—coronary artery disease	2.34e-05	0.000433	CcSEcCtD
Bezafibrate—Rash—Trandolapril—coronary artery disease	2.33e-05	0.000432	CcSEcCtD
Bezafibrate—Dermatitis—Trandolapril—coronary artery disease	2.33e-05	0.000431	CcSEcCtD
Bezafibrate—Rash—Enalapril—coronary artery disease	2.32e-05	0.00043	CcSEcCtD
Bezafibrate—Dermatitis—Enalapril—coronary artery disease	2.32e-05	0.00043	CcSEcCtD
Bezafibrate—Headache—Trandolapril—coronary artery disease	2.32e-05	0.000429	CcSEcCtD
Bezafibrate—Headache—Enalapril—coronary artery disease	2.31e-05	0.000427	CcSEcCtD
Bezafibrate—Pain—Timolol—coronary artery disease	2.31e-05	0.000427	CcSEcCtD
Bezafibrate—Nausea—Niacin—coronary artery disease	2.3e-05	0.000425	CcSEcCtD
Bezafibrate—Rash—Telmisartan—coronary artery disease	2.29e-05	0.000424	CcSEcCtD
Bezafibrate—Dermatitis—Telmisartan—coronary artery disease	2.29e-05	0.000424	CcSEcCtD
Bezafibrate—Diarrhoea—Furosemide—coronary artery disease	2.28e-05	0.000423	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.28e-05	0.000422	CcSEcCtD
Bezafibrate—Pruritus—Losartan—coronary artery disease	2.28e-05	0.000422	CcSEcCtD
Bezafibrate—Headache—Telmisartan—coronary artery disease	2.28e-05	0.000422	CcSEcCtD
Bezafibrate—Dizziness—Perindopril—coronary artery disease	2.27e-05	0.00042	CcSEcCtD
Bezafibrate—Insomnia—Lisinopril—coronary artery disease	2.26e-05	0.000419	CcSEcCtD
Bezafibrate—Nausea—Pravastatin—coronary artery disease	2.26e-05	0.000419	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Ramipril—coronary artery disease	2.26e-05	0.000418	CcSEcCtD
Bezafibrate—Rash—Captopril—coronary artery disease	2.23e-05	0.000413	CcSEcCtD
Bezafibrate—Dermatitis—Captopril—coronary artery disease	2.23e-05	0.000412	CcSEcCtD
Bezafibrate—Headache—Captopril—coronary artery disease	2.21e-05	0.00041	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Timolol—coronary artery disease	2.21e-05	0.000408	CcSEcCtD
Bezafibrate—Dizziness—Furosemide—coronary artery disease	2.2e-05	0.000408	CcSEcCtD
Bezafibrate—Dyspepsia—Lisinopril—coronary artery disease	2.2e-05	0.000408	CcSEcCtD
Bezafibrate—Diarrhoea—Losartan—coronary artery disease	2.2e-05	0.000408	CcSEcCtD
Bezafibrate—Nausea—Trandolapril—coronary artery disease	2.2e-05	0.000407	CcSEcCtD
Bezafibrate—Urticaria—Ramipril—coronary artery disease	2.19e-05	0.000406	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—coronary artery disease	2.19e-05	0.0197	CrCbGaD
Bezafibrate—Nausea—Enalapril—coronary artery disease	2.19e-05	0.000405	CcSEcCtD
Bezafibrate—Abdominal pain—Ramipril—coronary artery disease	2.18e-05	0.000404	CcSEcCtD
Bezafibrate—Rash—Perindopril—coronary artery disease	2.16e-05	0.000401	CcSEcCtD
Bezafibrate—Dermatitis—Perindopril—coronary artery disease	2.16e-05	0.0004	CcSEcCtD
Bezafibrate—Nausea—Telmisartan—coronary artery disease	2.16e-05	0.0004	CcSEcCtD
Bezafibrate—Headache—Perindopril—coronary artery disease	2.15e-05	0.000398	CcSEcCtD
Bezafibrate—Urticaria—Timolol—coronary artery disease	2.14e-05	0.000397	CcSEcCtD
Bezafibrate—Constipation—Lisinopril—coronary artery disease	2.14e-05	0.000396	CcSEcCtD
Bezafibrate—Pain—Lisinopril—coronary artery disease	2.14e-05	0.000396	CcSEcCtD
Bezafibrate—Abdominal pain—Timolol—coronary artery disease	2.13e-05	0.000395	CcSEcCtD
Bezafibrate—Dizziness—Losartan—coronary artery disease	2.13e-05	0.000394	CcSEcCtD
Bezafibrate—Rash—Furosemide—coronary artery disease	2.1e-05	0.000389	CcSEcCtD
Bezafibrate—Dermatitis—Furosemide—coronary artery disease	2.1e-05	0.000389	CcSEcCtD
Bezafibrate—Nausea—Captopril—coronary artery disease	2.1e-05	0.000389	CcSEcCtD
Bezafibrate—Headache—Furosemide—coronary artery disease	2.09e-05	0.000387	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Lisinopril—coronary artery disease	2.05e-05	0.000379	CcSEcCtD
Bezafibrate—Nausea—Perindopril—coronary artery disease	2.04e-05	0.000377	CcSEcCtD
Bezafibrate—Hypersensitivity—Ramipril—coronary artery disease	2.03e-05	0.000376	CcSEcCtD
Bezafibrate—Rash—Losartan—coronary artery disease	2.03e-05	0.000376	CcSEcCtD
Bezafibrate—Dermatitis—Losartan—coronary artery disease	2.03e-05	0.000375	CcSEcCtD
Bezafibrate—Headache—Losartan—coronary artery disease	2.02e-05	0.000373	CcSEcCtD
Bezafibrate—Urticaria—Lisinopril—coronary artery disease	1.99e-05	0.000368	CcSEcCtD
Bezafibrate—Hypersensitivity—Timolol—coronary artery disease	1.99e-05	0.000368	CcSEcCtD
Bezafibrate—Nausea—Furosemide—coronary artery disease	1.98e-05	0.000367	CcSEcCtD
Bezafibrate—Abdominal pain—Lisinopril—coronary artery disease	1.98e-05	0.000366	CcSEcCtD
Bezafibrate—Pruritus—Ramipril—coronary artery disease	1.95e-05	0.000361	CcSEcCtD
Bezafibrate—Indomethacin—ALB—coronary artery disease	1.95e-05	0.0175	CrCbGaD
Bezafibrate—Nausea—Losartan—coronary artery disease	1.91e-05	0.000354	CcSEcCtD
Bezafibrate—Pruritus—Timolol—coronary artery disease	1.91e-05	0.000353	CcSEcCtD
Bezafibrate—Diarrhoea—Ramipril—coronary artery disease	1.89e-05	0.00035	CcSEcCtD
Bezafibrate—Diarrhoea—Timolol—coronary artery disease	1.85e-05	0.000342	CcSEcCtD
Bezafibrate—Hypersensitivity—Lisinopril—coronary artery disease	1.84e-05	0.000341	CcSEcCtD
Bezafibrate—Dizziness—Ramipril—coronary artery disease	1.82e-05	0.000338	CcSEcCtD
Bezafibrate—Dizziness—Timolol—coronary artery disease	1.78e-05	0.00033	CcSEcCtD
Bezafibrate—Pruritus—Lisinopril—coronary artery disease	1.77e-05	0.000328	CcSEcCtD
Bezafibrate—Glyburide—ALB—coronary artery disease	1.76e-05	0.0158	CrCbGaD
Bezafibrate—Rash—Ramipril—coronary artery disease	1.74e-05	0.000322	CcSEcCtD
Bezafibrate—Dermatitis—Ramipril—coronary artery disease	1.74e-05	0.000322	CcSEcCtD
Bezafibrate—Headache—Ramipril—coronary artery disease	1.73e-05	0.00032	CcSEcCtD
Bezafibrate—Diarrhoea—Lisinopril—coronary artery disease	1.71e-05	0.000317	CcSEcCtD
Bezafibrate—Rash—Timolol—coronary artery disease	1.7e-05	0.000315	CcSEcCtD
Bezafibrate—Dermatitis—Timolol—coronary artery disease	1.7e-05	0.000315	CcSEcCtD
Bezafibrate—Headache—Timolol—coronary artery disease	1.69e-05	0.000313	CcSEcCtD
Bezafibrate—Dizziness—Lisinopril—coronary artery disease	1.65e-05	0.000306	CcSEcCtD
Bezafibrate—Nausea—Ramipril—coronary artery disease	1.64e-05	0.000303	CcSEcCtD
Bezafibrate—Nausea—Timolol—coronary artery disease	1.6e-05	0.000297	CcSEcCtD
Bezafibrate—Rash—Lisinopril—coronary artery disease	1.58e-05	0.000292	CcSEcCtD
Bezafibrate—Dermatitis—Lisinopril—coronary artery disease	1.58e-05	0.000292	CcSEcCtD
Bezafibrate—Headache—Lisinopril—coronary artery disease	1.57e-05	0.00029	CcSEcCtD
Bezafibrate—Nausea—Lisinopril—coronary artery disease	1.49e-05	0.000275	CcSEcCtD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.52e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—coronary artery disease	1.52e-06	3.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GYG1—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LDHA—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PFKM—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GK—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GATM—coronary artery disease	1.52e-06	3.71e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLCB3—coronary artery disease	1.5e-06	3.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—coronary artery disease	1.49e-06	3.66e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA5—coronary artery disease	1.48e-06	3.64e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—VCAN—coronary artery disease	1.47e-06	3.6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDOA—coronary artery disease	1.46e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—P4HB—coronary artery disease	1.45e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NOS3—coronary artery disease	1.45e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—coronary artery disease	1.45e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—coronary artery disease	1.45e-06	3.55e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AK1—coronary artery disease	1.45e-06	3.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCH1—coronary artery disease	1.45e-06	3.54e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.44e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARGC1A—coronary artery disease	1.43e-06	3.51e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	1.43e-06	3.5e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—coronary artery disease	1.43e-06	3.5e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AGT—coronary artery disease	1.42e-06	3.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DCN—coronary artery disease	1.41e-06	3.47e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.41e-06	3.46e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAT—coronary artery disease	1.41e-06	3.45e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—coronary artery disease	1.4e-06	3.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.4e-06	3.42e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—coronary artery disease	1.39e-06	3.41e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPAT—coronary artery disease	1.39e-06	3.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.39e-06	3.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UGCG—coronary artery disease	1.39e-06	3.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MDH2—coronary artery disease	1.39e-06	3.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDH2—coronary artery disease	1.38e-06	3.37e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOA1—coronary artery disease	1.37e-06	3.37e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOB—coronary artery disease	1.37e-06	3.35e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—VCAN—coronary artery disease	1.35e-06	3.3e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HBA1—coronary artery disease	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LIPC—coronary artery disease	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3C2A—coronary artery disease	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2C19—coronary artery disease	1.34e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDOA—coronary artery disease	1.34e-06	3.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGM1—coronary artery disease	1.33e-06	3.27e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOC3—coronary artery disease	1.33e-06	3.27e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—coronary artery disease	1.33e-06	3.26e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—coronary artery disease	1.33e-06	3.26e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LDLR—coronary artery disease	1.32e-06	3.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.32e-06	3.24e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.31e-06	3.22e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC9A1—coronary artery disease	1.31e-06	3.21e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—coronary artery disease	1.31e-06	3.21e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—LPL—coronary artery disease	1.3e-06	3.2e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—coronary artery disease	1.3e-06	3.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DCN—coronary artery disease	1.3e-06	3.18e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CETP—coronary artery disease	1.29e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCLC—coronary artery disease	1.29e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PYGB—coronary artery disease	1.29e-06	3.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CKB—coronary artery disease	1.29e-06	3.16e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SDC1—coronary artery disease	1.28e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPX1—coronary artery disease	1.27e-06	3.12e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDH2—coronary artery disease	1.26e-06	3.09e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD36—coronary artery disease	1.24e-06	3.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.23e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HBA1—coronary artery disease	1.23e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LIPC—coronary artery disease	1.23e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2C19—coronary artery disease	1.23e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	1.23e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	1.22e-06	3e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOC3—coronary artery disease	1.22e-06	2.99e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LDLR—coronary artery disease	1.21e-06	2.98e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DLAT—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—COX5B—coronary artery disease	1.21e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMA6—coronary artery disease	1.21e-06	2.96e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMB5—coronary artery disease	1.21e-06	2.96e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.21e-06	2.96e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—coronary artery disease	1.2e-06	2.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—coronary artery disease	1.2e-06	2.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC9A1—coronary artery disease	1.2e-06	2.94e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—coronary artery disease	1.19e-06	2.93e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCLC—coronary artery disease	1.19e-06	2.91e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CETP—coronary artery disease	1.19e-06	2.91e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CTGF—coronary artery disease	1.18e-06	2.89e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—coronary artery disease	1.17e-06	2.88e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SDC1—coronary artery disease	1.17e-06	2.87e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GOT2—coronary artery disease	1.17e-06	2.87e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMGCR—coronary artery disease	1.17e-06	2.87e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.15e-06	2.82e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—coronary artery disease	1.13e-06	2.76e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AGT—coronary artery disease	1.12e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMA6—coronary artery disease	1.11e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMB5—coronary artery disease	1.11e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.11e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.1e-06	2.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HK2—coronary artery disease	1.1e-06	2.69e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—coronary artery disease	1.09e-06	2.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—coronary artery disease	1.09e-06	2.67e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CTGF—coronary artery disease	1.08e-06	2.65e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOA1—coronary artery disease	1.08e-06	2.65e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLCB1—coronary artery disease	1.08e-06	2.64e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—coronary artery disease	1.07e-06	2.63e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GOT2—coronary artery disease	1.07e-06	2.63e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.07e-06	2.63e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.05e-06	2.59e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.05e-06	2.57e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCA1—coronary artery disease	1.04e-06	2.56e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NOS3—coronary artery disease	1.04e-06	2.55e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.04e-06	2.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.03e-06	2.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LCAT—coronary artery disease	1.03e-06	2.52e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA4—coronary artery disease	1.01e-06	2.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GOT1—coronary artery disease	1.01e-06	2.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GGT1—coronary artery disease	1.01e-06	2.47e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLCB1—coronary artery disease	9.86e-07	2.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PDHA1—coronary artery disease	9.76e-07	2.39e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCLM—coronary artery disease	9.76e-07	2.39e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	9.67e-07	2.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCA1—coronary artery disease	9.56e-07	2.34e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—coronary artery disease	9.53e-07	2.34e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—coronary artery disease	9.52e-07	2.33e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TXNRD1—coronary artery disease	9.46e-07	2.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP11B2—coronary artery disease	9.46e-07	2.32e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—coronary artery disease	9.4e-07	2.3e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC22A3—coronary artery disease	9.31e-07	2.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GOT1—coronary artery disease	9.25e-07	2.27e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GGT1—coronary artery disease	9.25e-07	2.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ARNTL—coronary artery disease	9.18e-07	2.25e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HADH—coronary artery disease	9.18e-07	2.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—coronary artery disease	9.07e-07	2.22e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	8.98e-07	2.2e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—coronary artery disease	8.94e-07	2.19e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—coronary artery disease	8.93e-07	2.19e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAT—coronary artery disease	8.82e-07	2.16e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—coronary artery disease	8.76e-07	2.15e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA2—coronary artery disease	8.7e-07	2.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX2—coronary artery disease	8.7e-07	2.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	8.7e-07	2.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SULT1A1—coronary artery disease	8.6e-07	2.11e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HK1—coronary artery disease	8.6e-07	2.11e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG5—coronary artery disease	8.6e-07	2.11e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX4—coronary artery disease	8.6e-07	2.11e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—coronary artery disease	8.58e-07	2.1e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—coronary artery disease	8.57e-07	2.1e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOB—coronary artery disease	8.57e-07	2.1e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HADHA—coronary artery disease	8.49e-07	2.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTA1—coronary artery disease	8.4e-07	2.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—coronary artery disease	8.33e-07	2.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—coronary artery disease	8.31e-07	2.04e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPA—coronary artery disease	8.3e-07	2.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	8.24e-07	2.02e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—coronary artery disease	8.2e-07	2.01e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NOS3—coronary artery disease	8.19e-07	2.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LPL—coronary artery disease	8.18e-07	2.01e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—coronary artery disease	8.17e-07	2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAT—coronary artery disease	8.09e-07	1.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCB3—coronary artery disease	8.04e-07	1.97e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPX1—coronary artery disease	7.98e-07	1.96e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA5—coronary artery disease	7.96e-07	1.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOB—coronary artery disease	7.85e-07	1.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—P4HB—coronary artery disease	7.81e-07	1.91e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD36—coronary artery disease	7.77e-07	1.91e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP2CA—coronary artery disease	7.67e-07	1.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	7.66e-07	1.88e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—coronary artery disease	7.64e-07	1.87e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LPL—coronary artery disease	7.5e-07	1.84e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—coronary artery disease	7.49e-07	1.84e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—coronary artery disease	7.36e-07	1.81e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPX1—coronary artery disease	7.32e-07	1.79e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—coronary artery disease	7.3e-07	1.79e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—VCAN—coronary artery disease	7.22e-07	1.77e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDOA—coronary artery disease	7.17e-07	1.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD36—coronary artery disease	7.12e-07	1.75e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP2CA—coronary artery disease	7.04e-07	1.72e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AGT—coronary artery disease	7e-07	1.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DCN—coronary artery disease	6.96e-07	1.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—coronary artery disease	6.86e-07	1.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA1—coronary artery disease	6.78e-07	1.66e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDH2—coronary artery disease	6.77e-07	1.66e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—coronary artery disease	6.75e-07	1.66e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—coronary artery disease	6.67e-07	1.64e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HBA1—coronary artery disease	6.6e-07	1.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LIPC—coronary artery disease	6.6e-07	1.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2C19—coronary artery disease	6.6e-07	1.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	6.6e-07	1.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOC3—coronary artery disease	6.55e-07	1.61e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LDLR—coronary artery disease	6.51e-07	1.6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.49e-07	1.59e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—coronary artery disease	6.44e-07	1.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC9A1—coronary artery disease	6.44e-07	1.58e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AGT—coronary artery disease	6.41e-07	1.57e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCLC—coronary artery disease	6.36e-07	1.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CETP—coronary artery disease	6.36e-07	1.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SDC1—coronary artery disease	6.29e-07	1.54e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—coronary artery disease	6.29e-07	1.54e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA1—coronary artery disease	6.21e-07	1.52e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—coronary artery disease	6.15e-07	1.51e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—coronary artery disease	5.97e-07	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.95e-07	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.94e-07	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.94e-07	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—coronary artery disease	5.89e-07	1.44e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—coronary artery disease	5.86e-07	1.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CTGF—coronary artery disease	5.81e-07	1.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.75e-07	1.41e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GOT2—coronary artery disease	5.75e-07	1.41e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—coronary artery disease	5.47e-07	1.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—coronary artery disease	5.4e-07	1.32e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—coronary artery disease	5.37e-07	1.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.29e-07	1.3e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NOS3—coronary artery disease	5.14e-07	1.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.13e-07	1.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GGT1—coronary artery disease	4.97e-07	1.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GOT1—coronary artery disease	4.97e-07	1.22e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—coronary artery disease	4.92e-07	1.21e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—coronary artery disease	4.78e-07	1.17e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NOS3—coronary artery disease	4.71e-07	1.15e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—coronary artery disease	4.7e-07	1.15e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	4.61e-07	1.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.46e-07	1.09e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.42e-07	1.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.4e-07	1.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAT—coronary artery disease	4.34e-07	1.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—coronary artery disease	4.31e-07	1.06e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOB—coronary artery disease	4.21e-07	1.03e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.1e-07	1.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPL—coronary artery disease	4.02e-07	9.87e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX1—coronary artery disease	3.93e-07	9.63e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD36—coronary artery disease	3.82e-07	9.37e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.78e-07	9.26e-06	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—coronary artery disease	3.77e-07	9.23e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.62e-07	8.88e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AGT—coronary artery disease	3.44e-07	8.44e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—coronary artery disease	3.37e-07	8.27e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA1—coronary artery disease	3.33e-07	8.18e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—coronary artery disease	2.94e-07	7.2e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—coronary artery disease	2.9e-07	7.1e-06	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—coronary artery disease	2.89e-07	7.09e-06	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—coronary artery disease	2.65e-07	6.5e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—coronary artery disease	2.64e-07	6.48e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NOS3—coronary artery disease	2.53e-07	6.2e-06	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—coronary artery disease	2.36e-07	5.79e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.31e-07	5.67e-06	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—coronary artery disease	2.16e-07	5.31e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.42e-07	3.49e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—coronary artery disease	1.16e-07	2.85e-06	CbGpPWpGaD
